Establishment of therapy for individual based on diagnostic imaging by artificial virus
基于人工病毒诊断成像的个体治疗的建立
基本信息
- 批准号:23659655
- 负责人:
- 金额:$ 2.33万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Challenging Exploratory Research
- 财政年份:2011
- 资助国家:日本
- 起止时间:2011 至 2012
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We revealed HGF/c-MET pathway reduced the efficacy of virus therapy through cancer-stroma interaction. To selectively detect the specific high-grade cancer cell population, we selected CXCR4 and c-MET and created selective MRI imaging agent.
我们发现HGF/c-MET通路通过癌间质相互作用降低了病毒治疗的疗效。为了选择性检测特定的高级别癌细胞群,我们选择了CXCR4和c-MET,并创建了选择性MRI显像剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Adenoviral Therapy Is More Effective in Gemcitabine-resistant Pancreatic Cancer than in Gemcitabine-sensitive Cells.
腺病毒治疗对吉西他滨耐药的胰腺癌比对吉西他滨敏感的细胞更有效。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:Takaharu Yasui;Kenoki Ohuchida;Ming Zhao;Lin Cui;Manabu Onimaru;Takuya Egami;Hayato Fujita;Takao Ohtsuka;Kazuhiro Mizumoto;Kunio Matsumoto;Masao Tanaka.
- 通讯作者:Masao Tanaka.
Inhibition of p600 expression suppresses both invasiveness and anoikis resistance of gastric cancer.
- DOI:10.1245/s10434-010-1523-0
- 发表时间:2011-07
- 期刊:
- 影响因子:3.7
- 作者:Sakai H;Ohuchida K;Mizumoto K;Cui L;Nakata K;Toma H;Nagai E;Tanaka M
- 通讯作者:Tanaka M
Claudin-4 Expression Predicts Survival in Pancreatic Ductal Adenocarcinoma
- DOI:10.1245/s10434-011-1970-2
- 发表时间:2012-07-01
- 期刊:
- 影响因子:3.7
- 作者:Tsutsumi, Kosuke;Sato, Norihiro;Tanaka, Masao
- 通讯作者:Tanaka, Masao
claudin-4発現は膵癌の予後予測因子として有用である
Claudin-4 表达可作为胰腺癌的预后因素
- DOI:
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:堤宏介;佐藤典宏;大内田研宙;大塚隆生;高畑俊一;中村雅史;水元一博;田中雅夫
- 通讯作者:田中雅夫
Tumor–stroma interactions reduce the efficacy of adenoviral therapy through the HGF‐MET pathway
- DOI:10.1111/j.1349-7006.2010.01783.x
- 发表时间:2011-02
- 期刊:
- 影响因子:5.7
- 作者:T. Yasui;K. Ohuchida;Ming Zhao;M. Onimaru;Takuya Egami;H. Fujita;T. Ohtsuka;K. Mizumoto;Masao Tanaka
- 通讯作者:T. Yasui;K. Ohuchida;Ming Zhao;M. Onimaru;Takuya Egami;H. Fujita;T. Ohtsuka;K. Mizumoto;Masao Tanaka
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TANAKA Masao其他文献
TANAKA Masao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TANAKA Masao', 18)}}的其他基金
A new strategy for improving the efficacy of the conventional therapy of pancreatic cancer by remodeling its microenvironment
通过重塑胰腺癌微环境提高胰腺癌常规治疗疗效的新策略
- 批准号:
25670586 - 财政年份:2013
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Identifying the leading cell for the invasion of pancreatic cancer
鉴定胰腺癌侵袭的主导细胞
- 批准号:
24390318 - 财政年份:2012
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Prospective isolation of pancreatic cancer cells with highly malignant phenotype and development of future individualized therapy
具有高度恶性表型的胰腺癌细胞的前瞻性分离和未来个体化治疗的发展
- 批准号:
21390381 - 财政年份:2009
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
ANALYSES OF THE SIGNAL TRANSDUCTION OF NOVEL ANTI-ARTHRITIC FACTOR, FRP, AND ITS EFFECTS ON IMMUNE SYSTEM
新型抗关节炎因子FRP的信号转导及其对免疫系统的影响分析
- 批准号:
18591105 - 财政年份:2006
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tailor-made NK4-gene therapy for pancreatic cancer using nano devise.
使用纳米装置针对胰腺癌量身定制 NK4 基因疗法。
- 批准号:
16209040 - 财政年份:2004
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A conceptual framework for the next generation of the supply chain management
下一代供应链管理的概念框架
- 批准号:
15530287 - 财政年份:2003
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis and modeling of micro- or nano-scale structure and microcirculation of bone
骨的微米或纳米级结构和微循环的分析和建模
- 批准号:
15086210 - 财政年份:2003
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Patient specific individual computational mechanics for diagnosis and treatment planning of temporomandibular joint disorder
用于颞下颌关节紊乱的诊断和治疗计划的患者特定个体计算力学
- 批准号:
14380402 - 财政年份:2002
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Treatment of pancreatic cancer by HGF antagonist, NK4, through new drug delivery system. -Approach from bench to practice
HGF 拮抗剂 NK4 通过新的药物输送系统治疗胰腺癌。
- 批准号:
13470257 - 财政年份:2001
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Patient specific indibidual computational bio-mechanics of temporomandibular joint system and application to temporomandibular disorder examination
患者颞下颌关节系统个体计算生物力学及其在颞下颌疾病检查中的应用
- 批准号:
12680830 - 财政年份:2000
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
SpyTCR-RBNP - Engineering a highly targeted and biocompatible drug delivery system for solid cancer treatment
SpyTCR-RBNP - 设计用于实体癌症治疗的高度针对性和生物相容性的药物输送系统
- 批准号:
10095606 - 财政年份:2024
- 资助金额:
$ 2.33万 - 项目类别:
Collaborative R&D
骨軟部肉腫に対するカーボン製drug delivery systemの開発
骨软组织肉瘤碳药物递送系统的开发
- 批准号:
24K12414 - 财政年份:2024
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Drug delivery system of osteoclast differentiation inhibitor with carbonate apatite
碳酸磷灰石破骨细胞分化抑制剂的给药系统
- 批准号:
23K16044 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Smart Nano-carrier for drug delivery system encapsulating peptide drug with high-efficiency
高效包裹肽类药物的药物递送系统智能纳米载体
- 批准号:
23K13803 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of Non-contact Nucleic Acid Drug Delivery System to Whole Body Skin - Challenge to SF Culture Tank -
开发全身皮肤非接触式核酸给药系统 - 挑战SF培养罐 -
- 批准号:
23K18592 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Pioneering research on development of "Drug Delivery System" for deworming gastrointestinal-infected Anisakis
开创性研究开发“药物输送系统”以驱除胃肠道感染的异尖线虫
- 批准号:
23K17446 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)
Development of an innovative drug delivery system for cancer therapy using platelets as vectors
使用血小板作为载体开发用于癌症治疗的创新药物输送系统
- 批准号:
23H02769 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of Drug Delivery System for RI Drugs Using Chromophore - Assisted Light Inactivation and Computational Science
利用发色团开发 RI 药物的给药系统 - 辅助光灭活和计算科学
- 批准号:
22KJ0538 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Topical Drug Delivery System as an Anti-Inflammatory and Pro-Angiogenic Therapy for Diabetic Wound Healing
局部给药系统作为糖尿病伤口愈合的抗炎和促血管生成疗法
- 批准号:
10696266 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
A novel drug delivery system for the prevention and rescue of fentanyl and other opioid overdoses
用于预防和救援芬太尼和其他阿片类药物过量的新型药物输送系统
- 批准号:
10636330 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别: